IDEXX LABORATORIES INC /DE Additional Paid in Capital, Common Stock
IDEXX LABORATORIES INC /DE (IDXX) had Additional Paid in Capital, Common Stock of $1.91 billion as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-04
- 2026-06-30: Additional Paid in Capital, Common Stock $1.91B.
- 2026-03-31: Additional Paid in Capital, Common Stock $1.86B.
- 2025-12-31: Additional Paid in Capital, Common Stock $1.83B.
- 2025-09-30: Additional Paid in Capital, Common Stock $1.79B.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-30 | $1.91B 10-Q · filed 2026-08-04 |
| 2026-03-31 | $1.86B 10-Q · filed 2026-05-05 |
| 2025-12-31 | $1.83B 10-Q · filed 2026-08-04 |
| 2025-09-30 | $1.79B 10-Q · filed 2025-11-03 |
| 2025-06-30 | $1.73B 10-Q · filed 2025-08-04 |
| 2025-03-31 | $1.70B 10-Q · filed 2025-05-01 |
| 2024-12-31 | $1.67B 10-K · filed 2026-02-20 |
| 2024-09-30 | $1.65B 10-Q · filed 2024-10-31 |
| 2024-06-30 | $1.63B 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.60B 10-Q · filed 2024-05-01 |
| 2023-12-31 | $1.57B 10-K · filed 2025-02-21 |
| 2023-09-30 | $1.54B 10-Q · filed 2023-11-01 |
| 2023-06-30 | $1.52B 10-Q · filed 2023-08-01 |
| 2023-03-31 | $1.49B 10-Q · filed 2023-05-02 |
| 2022-12-31 | $1.46B 10-K · filed 2024-02-22 |
| 2022-09-30 | $1.44B 10-Q · filed 2022-11-01 |
| 2022-06-30 | $1.42B 10-Q · filed 2022-08-02 |
| 2022-03-31 | $1.40B 10-Q · filed 2022-05-04 |
| 2021-12-31 | $1.38B 10-K · filed 2023-02-16 |
| 2021-09-30 | $1.36B 10-Q · filed 2021-11-02 |
| 2021-06-30 | $1.34B 10-Q · filed 2021-07-30 |
| 2021-03-31 | $1.32B 10-Q · filed 2021-05-04 |
| 2020-12-31 | $1.29B 10-K · filed 2022-02-16 |
| 2020-09-30 | $1.27B 10-Q · filed 2020-10-29 |
| 2020-06-30 | $1.25B 10-Q · filed 2020-07-31 |
| 2020-03-31 | $1.23B 10-Q · filed 2020-04-30 |
| 2019-12-31 | $1.21B 10-K · filed 2021-02-12 |
| 2019-09-30 | $1.19B 10-Q · filed 2019-10-31 |
| 2019-06-30 | $1.17B 10-Q · filed 2019-08-01 |
| 2019-03-31 | $1.16B 10-Q · filed 2019-05-01 |
| 2018-12-31 | $1.14B 10-K · filed 2020-02-14 |
| 2018-09-30 | $1.13B 10-Q · filed 2018-11-01 |
| 2018-06-30 | $1.11B 10-Q · filed 2018-08-01 |
| 2018-03-31 | $1.09B 10-Q · filed 2018-05-04 |
| 2017-12-31 | $1.07B 10-K · filed 2019-02-15 |
| 2017-09-30 | $1.06B 10-Q · filed 2017-10-31 |
| 2017-06-30 | $1.05B 10-Q · filed 2017-08-01 |
| 2017-03-31 | $1.03B 10-Q · filed 2017-04-28 |
| 2016-12-31 | $1.01B 10-K · filed 2018-02-16 |
| 2016-09-30 | $994.30M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $972.36M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $952.94M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $940.53M 10-K · filed 2017-02-17 |
| 2015-09-30 | $931.81M 10-Q · filed 2015-10-28 |
| 2015-06-30 | $921.68M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $912.58M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $888.29M 10-K · filed 2016-02-17 |
| 2014-09-30 | $866.21M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $856.35M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $847.14M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $825.32M 10-K · filed 2015-02-17 |
| 2013-09-30 | $798.33M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $787.19M 10-Q · filed 2013-07-23 |
| 2013-03-31 | $779.26M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $757.21M 10-K · filed 2014-02-18 |
| 2012-09-30 | $742.02M 10-Q · filed 2012-10-19 |
| 2012-06-30 | $726.62M 10-Q · filed 2012-07-20 |
| 2012-03-31 | $716.78M 10-Q · filed 2012-04-20 |
| 2011-12-31 | $702.58M 10-K · filed 2013-02-19 |
| 2011-09-30 | $694.20M 10-Q · filed 2011-10-21 |
| 2011-06-30 | $680.09M 10-Q · filed 2011-07-22 |
| 2011-03-31 | $665.03M 10-Q · filed 2011-04-21 |
| 2010-12-31 | $641.64M 10-K · filed 2012-02-17 |
| 2010-09-30 | $626.52M 10-Q · filed 2010-10-22 |
| 2010-06-30 | $613.42M 10-Q · filed 2010-07-23 |
| 2009-12-31 | $580.80M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |